Fate Therapeutics (FATE) Misses Q2 EPS by 6c

Go back to Fate Therapeutics (FATE) Misses Q2 EPS by 6c
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.13 +0.04 (1.91%)
Previous Close $2.09    52 Week High $4.76 
Open $2.07    52 Week Low $1.46 
Day High $2.15    P/E N/A 
Day Low $2.05    EPS $-1.91 
Volume 571,779